Patent for Klaria’s Sumatriptan Alginate Film to be Granted in Mexico
Klaria has received notification that the patent for its Sumatriptan Alginate Film will be granted in Mexico. This extends the geographic coverage of Klaria’s patent protection in the important North American market. The period of patent protected exclusivity in Mexico will last until 2037.UPPSALA, 11 January, 2021. An important part of Klaria’s intellectual property strategy is to file combination patents. These patents are specific for the combination of the active substance with the Alginate Film. The granting of the Sumatriptan Alginate Film combination patent in Mexico is further